155 related articles for article (PubMed ID: 25246162)
1. Pharmacokinetics of zolpidem from sublingual zolpidem tartrate tablets in healthy elderly versus non-elderly subjects.
Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Harris SC; Kapil RP
Drugs Aging; 2014 Oct; 31(10):731-6. PubMed ID: 25246162
[TBL] [Abstract][Full Text] [Related]
2. Comparison of pharmacokinetic profiles of zolpidem buffered sublingual tablet and zolpidem oral immediate-release tablet: results from a single-center, single-dose, randomized, open-label crossover study in healthy adults.
Greenblatt DJ; Harmatz JS; Roth T; Singh NN; Moline ML; Harris SC; Kapil RP
Clin Ther; 2013 May; 35(5):604-11. PubMed ID: 23541711
[TBL] [Abstract][Full Text] [Related]
3. Gender differences in pharmacokinetics and pharmacodynamics of zolpidem following sublingual administration.
Greenblatt DJ; Harmatz JS; Singh NN; Steinberg F; Roth T; Moline ML; Harris SC; Kapil RP
J Clin Pharmacol; 2014 Mar; 54(3):282-90. PubMed ID: 24203450
[TBL] [Abstract][Full Text] [Related]
4. Influence of food on pharmacokinetics of zolpidem from fast dissolving sublingual zolpidem tartrate tablets.
Greenblatt DJ; Harmatz JS; Singh NN; Roth T; Harris SC; Kapil RP
J Clin Pharmacol; 2013 Nov; 53(11):1194-8. PubMed ID: 23939537
[TBL] [Abstract][Full Text] [Related]
5. Pharmacokinetic effects of simultaneous administration of single-dose gabapentin 500 mg and zolpidem tartrate 10 mg in healthy volunteers: a randomized, open-label, crossover trial.
Galitz LA; Jayawardena S; Furey SA
Drugs R D; 2015 Mar; 15(1):71-7. PubMed ID: 25567214
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetic properties of zolpidem in elderly and young adults: possible modulation by testosterone in men.
Olubodun JO; Ochs HR; von Moltke LL; Roubenoff R; Hesse LM; Harmatz JS; Shader RI; Greenblatt DJ
Br J Clin Pharmacol; 2003 Sep; 56(3):297-304. PubMed ID: 12919178
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetic profile of a new modified release formulation of zolpidem designed to improve sleep maintenance.
Weinling E; McDougall S; Andre F; Bianchetti G; Dubruc C
Fundam Clin Pharmacol; 2006 Aug; 20(4):397-403. PubMed ID: 16867025
[TBL] [Abstract][Full Text] [Related]
8. Residual effects of low-dose sublingual zolpidem on highway driving performance the morning after middle-of-the-night use.
Vermeeren A; Vuurman EF; Leufkens TR; Van Leeuwen CJ; Van Oers AC; Laska E; Rico S; Steinberg F; Roth T
Sleep; 2014 Mar; 37(3):489-96. PubMed ID: 24587571
[TBL] [Abstract][Full Text] [Related]
9. Development of a Novel Oral Cavity Compartmental Absorption and Transit Model for Sublingual Administration: Illustration with Zolpidem.
Xia B; Yang Z; Zhou H; Lukacova V; Zhu W; Milewski M; Kesisoglou F
AAPS J; 2015 May; 17(3):631-42. PubMed ID: 25716146
[TBL] [Abstract][Full Text] [Related]
10. Potential pharmacokinetic basis for zolpidem dosing in children with sleep difficulties.
Blumer JL; Reed MD; Steinberg F; O'Riordan MA; Rosen CL; Springer MA; Christensen M; Glaze D;
Clin Pharmacol Ther; 2008 Apr; 83(4):551-8. PubMed ID: 17957186
[TBL] [Abstract][Full Text] [Related]
11. Pharmacokinetic interaction between zolpidem and carbamazepine in healthy volunteers.
Vlase L; Popa A; Neag M; Muntean D; Bâldea I; Leucuţa SE
J Clin Pharmacol; 2011 Aug; 51(8):1233-6. PubMed ID: 21098143
[TBL] [Abstract][Full Text] [Related]
12. Effect of fluvoxamine on the pharmokinetics of zolpidem: a two-treatment period study in healthy volunteers.
Vlase L; Popa A; Neag M; Muntean D; Achim M; Leucuţa SE
Clin Exp Pharmacol Physiol; 2012 Jan; 39(1):9-12. PubMed ID: 21985609
[TBL] [Abstract][Full Text] [Related]
13. Novel sublingual low-dose zolpidem tablet reduces latency to sleep onset following spontaneous middle-of-the-night awakening in insomnia in a randomized, double-blind, placebo-controlled, outpatient study.
Roth T; Krystal A; Steinberg FJ; Singh NN; Moline M
Sleep; 2013 Feb; 36(2):189-96. PubMed ID: 23372266
[TBL] [Abstract][Full Text] [Related]
14. Effect of CYP3A4 metabolism on sex differences in the pharmacokinetics and pharmacodynamics of zolpidem.
Yoon S; Jeong S; Jung E; Kim KS; Jeon I; Lee Y; Cho JY; Oh WY; Chung JY
Sci Rep; 2021 Sep; 11(1):19150. PubMed ID: 34580385
[TBL] [Abstract][Full Text] [Related]
15. Gender influences on efficacy and safety of sublingual zolpidem tartrate for middle-of-the-night awakening in insomnia.
Roth T; Steinberg F; Singh NN; Moline M
Hum Psychopharmacol; 2014 Jan; 29(1):25-30. PubMed ID: 24424704
[TBL] [Abstract][Full Text] [Related]
16. Coadministration of short-term zolpidem with sertraline in healthy women.
Allard S; Sainati SM; Roth-Schechter BF
J Clin Pharmacol; 1999 Feb; 39(2):184-91. PubMed ID: 11563412
[TBL] [Abstract][Full Text] [Related]
17. Drug interaction between St John's wort and zolpidem in healthy subjects.
Hojo Y; Echizenya M; Ohkubo T; Shimizu T
J Clin Pharm Ther; 2011 Dec; 36(6):711-5. PubMed ID: 21058968
[TBL] [Abstract][Full Text] [Related]
18. Sublingual zolpidem (Edluar™; Sublinox™).
Yang LP; Deeks ED
CNS Drugs; 2012 Nov; 26(11):1003-10. PubMed ID: 23034583
[TBL] [Abstract][Full Text] [Related]
19. Pharmacokinetics and safety of ezetimibe/simvastatin combination tablet: an open-label, single-dose study in healthy Chinese subjects.
Chu NN; Chen WL; Xu HR; Li XN
Clin Drug Investig; 2012 Dec; 32(12):791-8. PubMed ID: 23109219
[TBL] [Abstract][Full Text] [Related]
20. The effect of co-administration of zolpidem with fluoxetine: pharmacokinetics and pharmacodynamics.
Piergies AA; Sweet J; Johnson M; Roth-Schechter BF; Allard S
Int J Clin Pharmacol Ther; 1996 Apr; 34(4):178-83. PubMed ID: 8861737
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
